Elsevier, a global leader in research publishing and information analytics, has announced a new collaboration with LexisNexis Legal & Professional to strengthen the existing patent coverage in its information solution for chemistry R&D, Reaxys®. This integration gives companies and researchers access to the LexisNexis Intellectual Property patent content that powers LexisNexis PatentSight (Patent Analytics) and LexisNexis TotalPatent One (Patent Search) in their existing workflow.
Relevant patents for pharma and chemical R&D will be retrieved from 105 patent offices, 141m patent documents, and 56 full-text authorities. In addition, English language translations of foreign-language patents will also be available. The content expansion in Reaxys further cements its position as a comprehensive cheminformatics solution by ensuring companies and researchers do not miss key competitive intelligence insights.
Companies and researchers today are under immense pressure to innovate quickly and competitively. They need to answer a host of key questions: How is a given technology landscape evolving? Who else is working in the space? Where is the white space? Bringing together patent and biological/chemical R&D information in one interface makes it easier to review and researchers gain greater confidence in their decisions to accelerate R&D in pharma and chemicals.
Reaxys supports an enhanced competitive intelligence workflow with a user-friendly interface, relevant patent filters, ability to track and analyze data with the alert service, and export functions. In addition, cutting edge machine learning enables the accurate identification, extraction and curation of biological targets from the most relevant sources to support drug discovery workflows.
This is the beginning of a long-term collaboration between Elsevier and LexisNexis and represents a step change in the way both businesses address the needs of the market.
Click here to read the original press release.
